ATH 0.00% 0.3¢ alterity therapeutics limited

LLY change at the top., page-10

  1. 1,560 Posts.
    lightbulb Created with Sketch. 2
    kadaicher, Your repeated lack of correct interpretation of others' writing is frustrating. Read my reply to sg again. I was responding to his question to you regarding your apparent opinion of a fair shot (sg's words), not your "fair shots at goal" which you attribute to me. Confusing, huh... and very tiring.
    SG's subject of his short question was The Dish, nothing else, and my response to him was about nothing but The Dish....but you choose to not understand that.

    Once again I will remind you that your opinion about Prana's past trial phases are just that - your opinion, but not the opinion of experienced professional scientists and peer reviews none of which like you have praised PBT2's results, but they have recommended more work. For goodness sake, Prana has not ever been able to complete any Phase II that has shown positive-enough results to proceed to the absolute essential: late-stage trials to identify efficacy. Your opinion of Reach2HD Phase II cognitive improvement is entirely lacking since you insist that one of several secondary end points passed but the truth is that the other end points failed completely. What kind of reasoning is that? Not scientific!

    Again I point out your charitable habit of calling me a liar yesterday on Thanksgiving Day. You will be disappointed to learn that those of us who are thankful about many things had a wonderful peaceful holiday.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $4.606K 1.455M

Buyers (Bids)

No. Vol. Price($)
2 302058 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 138191331 31
View Market Depth
Last trade - 15.42pm 16/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.